Ausgabe 3/2024
Inhalt (12 Artikel)
Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits
Zixi Zhang, Cancan Wang, Tao Tu, Qiuzhen Lin, Jiabao Zhou, Yunying Huang, Keke Wu, Zeying Zhang, Wanyun Zuo, Na Liu, Yichao Xiao, Qiming Liu
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review
Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis
Hon Jen Wong, Norman H. Lin, Yao Neng Teo, Nicholas L. Syn, Yao Hao Teo, Ching-Hui Sia
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
Hasan Mushahid, Syeda Ayesha Shah, Syed Husain Farhan, Muhammad Hamza Shuja, Kyle Balasingam, Asad Ali Siddiqui, Ishaque Hameed, Kamran Akram, Shayan Mushahid, Muhammad Shariq Usman
Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry
Rengin Çetin Güvenç, Tolga Sinan Güvenç, Mert Efe Çağlar, Abdullah Ayar Al Arfaj, Ailin Behrad, Mehmet Birhan Yılmaz
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany
Alexander Michel, Coralie Lecomte, Christoph Ohlmeier, Hanaya Raad, Frederike Basedow, Dennis Haeckl, Dominik Beier, Thomas Evers
Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis
Ishaque Hameed, Syeda Ayesha Shah, Ashnah Aijaz, Hasan Mushahid, Syed Husain Farhan, Muhammad Dada, Adam Bilal Khan, Reeha Amjad, Fawad Alvi, Mustafa Murtaza, Zaid Zuberi, Mohammad Hamza
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020
Omar S. Alkhezi, Leo F. Buckley, John Fanikos
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China
Penglei Chen, Yixiang Wang, Xin Liu, Jiaqi Yu, Xuwei Zheng
Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study
Munaza Riaz, Jingchuan Guo, Steven M. Smith, Eric A. Dietrich, David E. Winchester, Haesuk Park
Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”
Hussain Sohail Rangwala, Hareer Fatima, Burhanuddin Sohail Rangwala
Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”
Ioannis Bellos, Smaragdi Marinaki, Pagona Lagiou, Vassiliki Benetou